The difference in association between aspirin use and other thrombocyte aggregation inhibitors and survival in patients with colorectal cancer

Author(s):
Frouws, M.A.; Rademaker, E.; Bastiaannet, E.; Herk-Sukel, M.P.P. van; Lemmens, V.E.; Velde, C.J.H. van de (0000-0003-0104-1800); Portielje, J.E.A.; Liefers, G.J.
Published
2017
Publication type
Article / Letter to editor
Platelet aggregation inhibitorsColorectal neoplasmsAspirinDipyridamoleClopidogrel
Date issued
2017-05-31
Language
English
Is part of
European Journal of Cancer (2017), Vol. 77, p. 24-30
hdl
1887/94933
doi
10.1016/j.ejca.2017.02.025